Cardiology

>

The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Latest News

Stephen Nicholls, MBBS, PhD | Credit: Monash University
Muvalaplin, an Oral Lp(a)-Lowering Agent, Shows Promise in Phase 2 KRAKEN Trial

November 19th 2024

Muvalaplin, an oral treatment, reduced Lp(a) by up to 85% in a 12-week Phase 2 trial presented at AHA 2024.

Steve Nissen, MD | Credit: Cleveland Clinic
Zerlasiran 60-Week Data Reinforce Lp(a) Reductions Observed in ALPACAR-360

November 18th 2024

Dhruv Kazi, MD | Credit: PCSK9 Forum
More than 50% of US Adults Considered Eligible for Semaglutide with Current Labeling

November 18th 2024

Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure| Image Credit: American Heart Association
Bumetanide Nasal Spray Equivalent to Oral, IV Forms for Heart Failure

November 18th 2024

Sacubtril/Valsartan Lowers Risk of Cardiotoxicity Linked to Chemotherapy | Image Credit: American Heart Association
Sacubtril/Valsartan Lowers Cardiotoxicity Risk Linked to Chemotherapy

November 18th 2024

Latest CME Events & Activities

Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes

View More

‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease

View More

Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis

View More

<1
...
247248249250251
© 2024 MJH Life Sciences

All rights reserved.